Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Company Profile Dancann Pharma AS (GM) DCPXF

DanCann Pharma A/S, a biopharmaceutical company, focuses on commercializing new therapeutic cannabinoids in various disease areas. The company distributes prescription cannabinoid-based medicines. It develops EXT03 CannGros, an oral extract based on Bediol; EXT04 CannGros, an oral extract based on Bedrolite; EXT02 CannGros, an oral extract based on Bedrocan; FLS04 CannGros granulate; FLS05... see more

Showcase News Releases

Showcase news

Silvercorp Metals Inc.
EARLY WARNING REPORT ISSUED PURSUANT TO NATIONAL INSTRUMENT 62-103
NurExone Biologic
NurExone Advances to Stage 2 of EU-Backed EIT Health Catapult Programme 2026
Mobix Labs Inc
Mobix Labs Announces Amendment to Senior Secured Convertible Note and Entry into Investor Rights Agreement with Leviston Resources

More Showcase News Releases »